The multi-injection modeling approach was used for the in vivo quantitation of benzodiazepine recep tors in baboon brain using positron emission tomography (PET) and [lIClflumazenil (RO 15-1788) as a specific ligand. The model included three compartments (plasma, free, and bound ligand) and five parameters (including the benzodiazepine receptor concentration). The plasma con centration after correction for the metabolites was used as the input function. The experimental protocol con sisted of four injections of labeled and/or unlabeled ligand. This protocol allows the evaluation, from a single experiment, of the five model parameters in various re gions of interest. For example, in the temporal cortex, the concentration of receptor sites available for binding
(B;"ax) and the equilibrium dissociation constant (Kd) were estimated to be 70 ± 15 pmollml and 15.8 ± 2.2 nM, respectively. The validity of the equilibrium approach, which is the most often used quantitation method, has been studied from simulated data calculated using these model parameters. The equilibrium approaches consist of reproducing in PET studies the experimental conditions that permit the use of the usual in vitro methods such as Recent developments in in vivo ligand binding methods using positron emission tomography (PET) have allowed the possibility of studying the distri bution of neuroreceptors in the living brain. The benzodiazepine receptors have been studied in ba-Scatchard analysis. These approaches are often open to criticism because of the difficulty of defining the notion of equilibrium in in vivo studies. However, it appears that the basic relation of Scatchard analysis is valid over a broader range of conditions than those normally used, such as the requirement of a constant bound/free ratio. Simulations showed that the values of the receptor con centration (B;"ax) and the equilibrium dissociation con stant (Kd) found using Scatchard analysis are always un derestimated. These simulations also suggest an explana tion concerning the dependency of B;"ax and Kd on the time point employed for the Scatchard analysis, a phe nomenon found by several authors. To conclude, we pro pose new protocols that allow the estimation of the B;"ax and Kd parameters using a Scatchard analysis but based on a protocol including only one or two injections. These protocols being entirely noninvasive, it thus becomes possible to investigate possible changes in receptor den sity and/or affinity in patients. Key Words: Benzodiaze pine receptors-[ llCjFlumazenil-Positron emission to mography-Compartmental model-Equilibrium ap proaches.
boons and in humans using [llC] flumazenil , an an tagonist with a high affinity and selectivity for cen tral benzodiazepine receptors (Comar et aI ., 1979; Maziere et aI ., 1983 ; Persson et aI ., 1985; Samson et aI ., 1985) . A quantitative analysis of the in vivo ki netics of flu maze nil in the brain is essential for un derstanding the pharmacological properties of ben zodiazepine receptor ligands and the role of the binding sites for benzodiazepines in pathological conditions. In particular, changes in the density or affinity of a specific receptor system in discrete brain regions may be important in pathophysiology or neurology disorders . One of the challenges of in vivo PET studies of ligand-receptor interactions is the quantitation of these two parameters.
However, PET measurements of the ligand con centration do not allow the receptor concentration to be directly deduced ; it is necessary to use kinetic data and a mathematical model describing the ligand-receptor interactions (see, for example, Min tun et aI ., 1984; Syrota et aI., 1984; Vera et aI ., 1985 ; Perlmutter et aI ., 1986; Wong et aI ., 1986; Logan et aI ., 1987) . All of the in vivo approaches are based on a mathematical model that includes at least two steps: first, a transport of the ligand from the blood to a fr ee ligand compartment (a necessary step since the labeled ligand is intravenously in jected) , and , second, a classical ligand-receptor in teraction similar to that used in in vitro studies. Therefore, the model includes at least five parame ters (four kinetic parameters and B:nax, the concen tration of the receptor sites available for binding) .
One purpose of this study is to characterize the kinetics of [ ll C]flumazenil in the baboon brain . We have used the modeling approach based on a fitting procedure that allows the identification of all model parameters from kinetic curves provided by a single dynamic PET experiment. Previous studies have shown that e l C]flumazenil possesses most of the favorable characteristics necessary to allow the modeling of the ligand-receptor interactions. This ligand has a high blood-brain barrier permeability and a very high specific/nonspecific binding ratio . The lack of adverse effe ct of flumazenil, even at large doses (Darragh et aI ., 1983) , makes this drug a ligand of choice to perform saturation and displace ment experiments in humans.
The main constraints of these kinetic approaches are the need to measure the model input fu nction and to maintain a balance between the respective complexities of the model structure and of the ex perimental protocol (Delforge et aI. , 1990a) . It is obvious that the estimation of five or more param eters is possible only by using complex experimen tal protocols, such as proposed by the multi injection modeling approach, which has been al ready successfully used both in heart studies (Delforge et aI ., 1990b (Delforge et aI ., , 1991a and in brain studies (Delforge et aI ., 1991b) .
However, this modeling approach may be consid ered too complex and some authors proposed an other way , which consists of reducing the number of model parameters to be identified. Usually, some hypotheses are introduced in order to simplify the model (such as some equilibrium hypotheses), or the receptor concentration variations are studied through some indexes assumed to be correlated with the receptor concentration (such as the ratio of the concentration in the region of interest to the concentration in a receptor-poor region) . These sorts of hypotheses can be very useful if they pro vide a way of estimating the receptor concentration variations that are easily usable in clinical routine . However, the results obtained by such simplified methods can be considered valid only when the hy potheses are proven to be entirely justified. One of the interests in the identification of the complete model is to obtain a tool that allows the simulation of the simplified methods and therefore evaluates the validity of the hypotheses invoked.
The two main parameters to be identified , the concentration of receptor sites Bmax and the equi librium dissociation constant K d , concern only the interactions between the fr ee ligand and the recep tor sites . It is inviting to eliminate the study of the transfer kinetics between the blood and the free ligand compartment and thus to concentrate our at tention only on the association and dissociation be tween the ligand and the receptor sites. Thus , many authors would like to use in PET studies the usual in vitro methods , such as the Scatchard analysis based on the equilibrium relation
which is valid if the system is in an equilibrium state . In this equation, Band F represent the bound and the fr ee ligand concentrations , respectively. A plot of B/ F versus B gives a straight line whose slope is the inverse of K d , and the intercept with the B axis gives the concentration of receptors , B:nax' In this approach, the main difficulties are , first, to es timate separately the free and the bound ligand con centrations (the PET data giving only the sum of these two concentrations), and, second, to obtain a large range of bound ligand concentrations, which leads the investigators to perform several experi ments with various specific activities (obtained by injecting various doses of unlabeled ligand simulta neously with the tracer radioligand) . In spite of these inconveniences, this approach is the most of ten used method of quantitation of benzodiazepine receptors because of its advantages, e.g., the ab sence of blood sampling (Pappata et aI ., 1988; Pers son et aI ., 1989; Brouillet et aI ., 1990; Price et a1., 1990 Price et a1., , 1991 ; Abadie et aI ., 1991; Iyo et aI ., 1991) .
Using the complete model parameters , identified with the multi-injection approach, this Scatchard equilibrium approach was simulated in order to es timate its validity , which is often open to criticism because of the difficulty of defining with precision the notion of equilibrium in in vivo experiments. These simulation studies suggested a possible ex planation concerning the dependency of B:nax and K d on the time point used for the Scatchard analy sis, a phenomenon fo und by several authors (Pap pata et aI ., 1988; Persson et aI ., 1989; Brouillet et aI ., 1990; Price et aI., 1991) .
METHODS

Animal preparation
Male Papio papio baboons, weighing 16 to 21 kg, were lightly anesthesized and immobilized according to a pre viously described procedure (Maziere et aI., 1981) . A catheter was placed in a brachial vein to inject ligand, while a second catheter was inserted in the femoral artery to withdraw arterial blood samples.
Synthesis of [ ll C]flumazenil ([ ll C]FMZ)
Flumazenil (RO 15 1788) was labeled with carbon-II using the methylation process described by Maziere et aL (1984 At times 40 and 80 min, two intravenous injections of an excess of unlabeled ligand were performed (displacement injections). The ligand amounts, denoted by J I and J2, were 0.2 or 0.5 mg, respectively.
At times ranging from 120 to 138 min, a fourth injection was performed, consisting of a mixture of labeled (�40 mCi) and unlabeled FMZ in the same syringe (coinjec tion). The injected [IIC]FMZ amounts (Jj) ranged from 19 to 67 fLg; those of unlabeled ligand (J3) were 0.5 or 1 mg.
The total experiment lasted 200 min. Details of the doses administered are given in Table 1 .
PET measurements
The PET studies were performed using the seven-slice time-of-flight assisted positron camera (LETI TTV03, C.E.A., France) (Trebossen and Mazoyer, 1991) . The ax ial resolution is 9 mm full width at half-maximum (FWHM) and the spatial transverse resolution about 7 mm. Transmission scans were performed with a rotating 68Ge_68Ga source to correct emission scans for the atten uation of 511 ke V photon rays through the tissues and the head support. Emission data were recorded in list mode starting with the first injection of [l1C]FMZ until the end of the experiment. One hundred six sequential PET scans of increasing duration after each injection of labeled FMZ (10 to 5 min) were reconstructed.
For data analysis, circular regions of interest were drawn on selected PET images in order to involve the cerebellum and the occipital, temporal, and frontal corti ces. Anatomical localization of these regions was chosen according to corresponding histological cross sections of the baboon brain (Riche et aI., 1988) . The concentration of radioactivity in the different regions of interest was calculated for each sequential scan and plotted versus time.
Radioactivity was measured in the selected cerebral structures after correction for l1C decay and expressed as pmollml after normalization using the corresponding spe cific radioactivity measured at the time of injection. At the time of the second tracer injection of [l1C]FMZ, the brain radioactivity resulting from the first injection was assumed to be negligible, compared to the radioactivity resulting from the second tracer injection, because of the six periods of IIC decay and the tissue washout resulting from the two displacement injections.
Plasma concentration measurements and model input function
Since the nonmetabolized plasma time-concentration curve is used as the input function in the model, 70 arte rial blood samples (of �0.3 ml) were collected from the femoral artery. The time interval between each sample varied. Samples were taken every 5 s during the 2 min following each injection of labeled FMZ. The sampling interval increased to 10 min when the change in the blood radioactivity concentration slowed down. After rapid blood centrifugation, the plasma IIC radioactivity was measured using a gamma counting system (CG 4000, Kronton, France). Then, the time-activity curves were corrected for physical decay of lIC activity and the plasma radioactivity concentrations were transformed in FMZ time-concentration curves using the corresponding specific radioactivity of [lIC]FMZ. After the second tracer injection of [lIC]FMZ, the plasma radioactivity re sUlting from the first injection is assumed to be negligible, compared to the radioactivity resulting from the second tracer injection, because of the six periods of IIC decay and the natural decrease in the [lIC]FMZ plasma concen tration.
The fraction of nonmetabolized [lIC]FMZ in plasma decreased rapidly following administration. It has been previously shown that FMZ metabolites cannot cross the blood-brain barrier (Inoue et ai. , 1985) . Thus, the non metabolized [llC]FMZ plasma concentration is used as the input function into the model C:(t). This curve was deduced from the plasma time--concentration curve by using the results of Loc'h et ai. (1990) . The percentage of nonmetabolized [IIC]FMZ concentration in plasma is given by the biexponential curve P nm(t) = 44 e -0. 36t + 62 e -O.OO l t (2) where t is the time expressed in minutes and P nm(t) the % of nonmetabolized [IIC]FMZ.
The ligand-receptor model
The compartmental model used in this study and shown in Fig. 1 is a nonequilibrium nonlinear model (Syrota et aI., 1984 (Syrota et aI., , 1985 Delforge et ai. , 1990a Delforge et ai. , , 1991a . The flux of nonmetabolized free ligand from the plasma compartment to the free ligand compartment is given by pVR C:(t) (as pmol min -l/ml of tissue). C:(t) is the plasma concentra tion of non metabolized [lIC]FMZ (as pmoUml of plasma), p is a rate constant (permeability, as ml of plasma min -I I ml of tissue) and VR (as ml of tissue/ml of tissue) is de fined as the fraction of the region of interest occupied by the free ligand and thus the fraction of this volume is which the free ligand can react with receptors. The quan tity of radioactive free ligand present in 1 ml of the tissue volume delineated by PET is denoted by Mi and there fore the free ligand concentration in the volume of reac tion VR is given by MiIVR. The free ligand could bind directly to a free receptor site or escape with a rate con stant k. The specific binding probability depends on the bimolecular association rate constant (k + I ) and on the local concentration of free receptor sites, which is equal to [B:nax -M�(t)]. The parameter B:nax represents the unknown quantity of receptor sites available for binding and M�(t) is the quantity of labeled ligand bound to re ceptors in 1 ml of tissue. The rate constants for the dis sociation of the specifically bound ligand is denoted by L I' This model does not include nonspecific binding since it has been shown that the nonspecific binding of FMZ can be considered in vivo as negligible (Goeders and Kuhar, 1985) . Moreover, if a weak nonspecific binding exists, it would be lumped in with the free ligand com partment (Mintun et ai. , 1984; Perlmutter et ai. , 1986) .
The protocol described in a previous section includes injections of unlabeled ligand during displacement and coinjection experiments. Thus, the kinetics of the unla beled ligand aff ect the local concentration of free receptor sites and must therefore be taken into account. Amounts of free unlabeled ligand are denoted by Mit) and specif ically bound unlabeled ligand by Mb(t). They are ex pressed as pmoUml of tissue. The unlabeled ligand kinet-ics were assumed to be similar to that of the labeled ligand and thus the two parts of the model, associated with the labeled and unlabeled ligand, have the same structure and the same parameters. The plasma concentration of the unlabeled ligand [denoted by Ca(t)] was calculated by simulation, using the curve C:(t) corresponding to the labeled ligand. It is assumed that non metabolized plasma curves have similar shapes and are proportional to the mass injected for each separate injection. Comparison of the plasma curves after a tracer injection and after a coin jection justifies this assumption.
Parameter identification and simulations of labeled and unlabeled ligand kinetics were performed using the fol lowing equation system (which corresponds to the model diagram of Fig. 1) :
where B:nax, pVR, k, k+ I IVR, and k_ 1 are the unknown parameters. Units are given in Tables 2 and 3. In PET studies, experimental data [denoted by M¥-(tj)] acquired between two times (denoted by t; _ I and t;) is given by the following integral relation:
.
where CMt) is the whole blood time--concentration curve and where F v represents the fractional volume corre sponding to the fraction of blood present in the tissue volume. In this study, Fv is assumed to be 0.04 (Perlmut ter et ai. , 1986; Farde et aI. , 1989; Koeppe et ai. , 1991) . The model parameters are identified by means of min imization of the usual weighted least-squares cost func tion and the estimation of the standard errors is based on the use of a sensitivity analysis and the covariance matrix (Beck and Arnold, 1977; Carson, 1986; Delforge et ai. , 1989) . Figure 2 shows two examples of time-concen tration curves obtained with this multi-injection protocol. These two curves correspond to the oc cipital cortex and cerebellum data obtained during experiment 4 (see the exact protocol in Table 1 ). After the first injection of [I l C]FMZ with high spe cific activity , the radioligand concentration in creased and reached the maximum -15 min after Compartmental ligand-receptor model used in the analysis of brain tissue data obtained after intravenous injection of ["C]FMZ. The upper part represents the pos sib le model describing the kinetics of the ra dioligand (quantities denoted with a star su perscript) and the lower part the sa me model associated with the unlabeled ligand. All transfer probabilities of ligand between compartments are linear except the binding probability, which depends on the bimolec ular association rate constant (k + ,IVR) and on the local concentration of free receptor
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imental data correspond to the sum of the injection (0.0 144 ± 0.0025 pm01lml per nmol/kg in jected for the occipital cortex and 0.0101 ± 0.00 15 pmollml per nmollkg injected for the cerebellum, n = 6) . The first injection of a large amount (0.2 mg) of unlabeled ligand at 40 min resulted in a rapid de crease in the [ ll C]FMZ concentration, showing a fast dissociation of the labeled bound ligand fr om the receptor sites. Twenty minutes later, the de crease was negligible and the curve became a pla teau. A second displacement at 80 min (injection of 0.2 or 0.5 mg of FMZ) resulted in a new decrease in [ ll C]FMZ concentration followed by a new plateau � 10 min after. The percentages of displacement ob served were large (�50% in Fig. 2 ) although they were smaller than the percentage of displacement obtained at 40 min (�78% in Fig. 2 ).
The coinjection of labeled and unlabeled FMZ at 120 min produced a fa st peak in time-concentration curves, which contrasted with smoother curves ob served when labeled ligand was injected alone. The curves were always decreasing during the 80 min after this last injection.
Parameter identification
Fitting the mathematical model to experimental data provided values for kinetic rate constants and receptor densities. Table 2 shows the example of the individual parameter estimates corresponding to the temporal cortex data obtained during the six experiments. An estimate of the standard error was obtained for each identified parameter using the co variance matrix. This value corresponds to the er ror estimates resulting from the differences between the model-predicted values and the experimental data (which can be observed in Fig. 2 ) due to the experimental uncertainties and to the simplified structure of the model compared to the biological reality. Average parameter values and standard de viations were calculated for the six animals. These standard deviations often appear to be significantly larger than the individual standard errors (see the examples of B:n a x and of K d V R)' This means that, with this experimental protocol, the influence of various uncertainties (such as the individual vari ability, the various instrumental errors, and the un certainties on the specific activity , on the blood sample concentrations and on the metabolite cor rection) was more significant than the consequence of the differences between the model-predicted con centrations and the experimental data. Table 3 shows the means and the standard devi ations obtained in the four regions of interest. The largest receptor density is found in the occipital cor- One of the interesting features of the modeling approach is the possibility to simulate the time concentration curve in all compartments . As an ex ample , Fig. 3A shows the simulation of the labeled fre e, bound, and total ligand concentrations calcu lated using the model parameters obtained from the occipital cortex data during experiment 4 (see the detailed protocol in Table 1 and the parameter val- Table 1 ).
ues in the legend of Fig. 3 ) . The concentration mea sured with PET (shown both in Figs. 2 and 3A by a solid line) was the sum of e'C] FMZ concentrations in the free and bound compartments and of a frac tion F v of the blood compartment assumed to be equal to 4% in this study . Figure 3B represents the associated simulation of the kinetics of the unla beled free and bound ligand . In Fig. 4 , the solid line represents the ratio of the labeled fr ee to the labeled bound ligand concentrations .
These computer simulations showed that most of the radioligand was specifically bound to receptors after the high specific-activity injection (89% at 30 min) and that the ratio of bound/free (8.6) was al most constant during the period (20-40 min) (see Fig. 4 ) . The two injections of unlabeled ligand at 40 and 80 min led to a large percentage of receptor sites occupied by the unlabeled ligand (about 84 and 89%, respectively; see Fig. 3B ). Each of these two injections caused a rapid decrease in the labeled bound ligand concentration and a temporary in crease in the free ligand concentration. However, the concentration of labeled bound ligand remained higher than that of the free ligand and the ratio of bound/free remained variable (see Fig. 4 ) . For ex ample , during the period of 90-120 min, the con centration of labeled bound ligand appeared to be constant whereas that of the labeled fr ee ligand de creased (see Fig. 3A ) . Two minutes after the coin jection at 120 min, 96.4% of the receptors were oc cupied (94.9% by unlabeled ligand and 1.5% by la beled ligand) . The concentration of free labeled ligand increased rapidly and became larger than the bound ligand concentration for a short period. However, the bound ligand concentration remained preponderant at the end of the experiment and the ratio of bound/free was still variable 80 min after this last injection.
Computer simulation of the
Scatchard-equilibrium approach
In the equilibrium approaches, the protocol con sists of a series of experiments (at least three, usu-ally from five to eight) , each using a single coinjec tion of a tracer amount of labeled ligand with a vari able amount of unlabeled ligand. The main difficulty is to estimate separately the free and the bound ligand concentrations since, by assuming that the vascular fraction can be neglected, the PET data give only the sum of these two concentrations. A good estimation of the free ligand concentration is all the more important as the Scatchard analysis 2). The model parameters were B;"'ax = 64.7 pmol/ml, k+ 1 /VR = 0.083 ml/(pmol min),L 1 = 0.61 min-1,pVR = 0.27min-1, and k = 0.45 min-1. Figure 3A shows the simulation of the kinetics of [11C]FMZ. The dotted line corresponds to the la beled free ligand (compartment 2), the long-dashed line to the labeled specifically bound ligand (compartment 3), and the short-dashed line to the vascular fraction of the blood concentration. The solid line represents the simulated exper imental data, which consists of the sum of the concentra tions of these two extravascular compartments and of the vascular fraction of the blood concentration (estimated here to be equal to -4%). Figure 38 shows the simulation of the kinetics of unlabeled FMZ. The dotted line corresponds to the unlabeled free ligand and the long-dashed line to the unlabeled bound ligand. uses the bound/free ratio and thus the free ligand concentration is in the denominator. Two different methods are used. The first one is a full-saturation experiment, which consists of simultaneously in jecting labeled and unlabeled FMZ, the dose of un labeled FMZ being large enough to result in all of the receptor sites being occupied up to the end of the experiment. It was assumed that this curve rep re sents the free ligand concentration due to the very low nonspecific binding of FMZ (Pappata et aI ., 1988; Iyo et aI ., 1991) . The second method consists of using the concentration in a receptor-poor region (pons or white matter) as an estimate of the free ligand concentration (Persson et aI ., 1989; Abadie et aI ., 1991 ; Price et aI ., 1991) . A third approach exists in which the fr ee ligand concentration is estimated using a nonbinding enantiomer, but this approach is not used with FMZ. In order to test the equilibrium approach based on a Scatchard analysis, this method has been sim ulated using the model parameters corresponding to the occipital cortex (see Table 3 ) and the plasma time-concentration curve of experiment 4. Figure 5 shows the simulated experiment data set that was obtained by simulating PET experiments consisting of a simultaneous injection at time zero of 4.5 j.Lg of [ ll C]FMZ and of doses of unlabeled FMZ ranging fr om 0 to 2.5 mg/kg of body weight (see the exact doses in the Fig. 5 legend) . The shapes .of this ki netic curve set appear to be similar to the experi mental data set obtained, for example , by Pappata et ai . (1988) and Brouillet et ai . (1990) . With a large and increasing dose of unlabeled ligand, the PET curves tend to an asympotic curve. In such a full- saturation experiment, all of the receptors sites are occupied and this asympotic curve is assumed to represent the concentration of free radioligand (P).
QUANT/TATION OF BENZODIAZEPINE RECEPTORS
The specific binding in the occipital cortex (B) is calculated as the total concentration of radioligand minus the corresponding concentration obtained in the same region of interest during the fu ll-saturation experiment (Pappata et aI., 1988; Brouillet et aI ., 1990) . Figure 6A shows the Scatchard plot (BIF ver sus B) obtained from the simulated concentration values estimated at 10 min intervals for different times (from 20 to 60 min) , each time being repre sented by a different symbol. In the same figure , the solid straight line represents the theoretical Scatch ard plot, the intercept of this straight line at the bound ligand concentration axis giving B:nax (75 pmollml) , and the inverse of the slope giving Kd VR (8.4 pmollml) . A bias is observed between the sim ulated points and the theoretical curve , the ratio of BI F being overestimated for low bound ligand con centrations whereas it was underestimated for high bound ligand concentrations. However, no effe ct of the time chosen for the Scatchard analysis is pointed out. This simulation led to the estimations of B:nax and KdVR equal to 67 and 5.4 pmollml, re spectively, which correspond to underestimates of 12 and 35%, respectively.
Explanation of the bias
Two approximations can explain this bias: the ap proximation concerning the validity of the equilib rium relation and the approximation associated with the estimation of the free ligand concentration by a fu ll-saturation experiment. To eliminate the first the inverse of the slope is equal to KdVR (8.4 pmol/ml). In Fig. 6A , the free ligand concentration was estimated from the full saturation experiment (curve of Fig. 5 corresponding to an injec tion of unlabeled ligand equal to 2.5 mg/kg). In Fig. 68 , the free ligand concentration was given by simulation (see Fig. 3A ) and thus assumed to be known without errors. The figure demon strates that the approximation about the validity of the equilibrium relationship leads to a negligible bias. In Fig. 6C , the free ligand concentration was estimated using the curve corresponding to an injection of unlabeled ligand equal to 0.25 mg/kg (see Fig. 5 ), which is a dose not large enough to obtain a full-saturation ex periment. Contrary to Fig. 6A , one observes a dependence of the curve on the time considered for the Scatchard analysis. possibility , the equilibrium Scatchard analysis was simulated using the fr ee and bound ligand concen trations given by simulations and thus assumed to be known without error. The Scatchard plot ob tained with this method is shown in Fig. 6B . The bias observed in this figure, and resulting only from the approximation about the validity of the equilib rium relation, appeared to be negligible. In fact, the overestimation of the bound/free ratio for the low bound ligand concentrations results from a surprising underestimation of the free ligand concentration by using the fu ll-saturation experi ment. Indeed, common sense leads one to think that, when the tissue contains receptors , a part of the free ligand binds to these receptors and thus leads to a smaller fr ee ligand concentration, com pared to that obtained in a tissue containing few fr ee receptor sites (receptor-poor tissue or receptors previously occupied by unlabeled ligand). Figure 7 shows that this is clearly true for the first 10 min. However, when the ligand previously bound to re ceptors dissociates, it increases the free ligand con centration. This is evident in Fig. 7 by comparing the concentration between the fu ll-saturation exper iment (solid line) and the tracer injection experi ment (solid circle), the first curve lying above the second before 10 min and below it after this time. This underestimation of the fr ee ligand concentra tion is significant for the doses of unlabeled ligand ranging from 0 to 5 j.Lg/kg , which corresponds to the bound ligand concentrations ranging fr om 0 to 30 pmol/m1. For example, an underestimation of the 2 � '0 E .8: free ligand concentration of 20% (observed with the tracer injection) led to a small overestimate of the bound ligand concentration (3%) but above all to a significant overestimate of the bound/free ratio (-25%) . When the dose of injected unlabeled ligand was very large (for example, 0.25 mg/kg, which is 10 times larger than the dose injected during the ex periment corresponding to Figs. 2-4) , the concen tration of fr ee ligand remained high enough that the percentage of free receptor sites was always less than several percent (-4% in the 0.25 mg/kg exper iment). In such a case, the estimation of the free ligand concentration using the full-saturation exper iment is not disturbed by the dissociated ligand. The previous reasoning explaining the overestimation of the free ligand concentration during the first 10 min (see Fig. 7 ) is now true whatever the time, and the fu ll-saturation method leads to a small overestimate of the free ligand concentration (about 6% with the 0.25 mg/kg curve), which is difficult to see in Fig. 7 . However, this leads to an underestimation of the bound ligand concentration (10% in the example) , which is the more significant as this concentration is calculated by subtracting very nearly equal data (i.e., as the unlabeled dose is high). This explains the curious B/ F versus B curve observed for the high bound ligand concentrations.
Time dependence of the B:ru.x estimates
In most of the studies based on this equilibrium approach, the authors found a receptor concentra tion depending on the time considered for the Scat chard analysis (Pappata et aI. , 1988; Persson et aI. , 1989 ; Price et aI. , 1991) . The variations were always the same: the B:nax and Kd values were decreasing with time. We suggest that this phenomenon results fr om an insufficient unlabeled ligand dose injected during the full-saturation experiment. In Fig. 6A , the Scatchard plot has been obtained by using a fu ll-saturation experiment, the simulation curve corresponding to an injected unlabeled ligand dose equal to 2.5 mg/kg. In this figure , no influence of the time considered for the Scatchard analysis is ob served. Figure 6C shows the Scatchard plot ob tained fro m the same simulated data set but in which the experiment used as the full-saturation ex periment is the simulated curve obtained with an unlabeled dose equal to 0.25 mg/kg. This figure clearly demonstrates a dependence of the curve on the Scatchard analysis time, with the estimated con centration of receptor sites that appeared to de crease with time. This 0.25 mg/kg dose is to be com pared with the 0.3 mg/kg used by Pappata et a1. (1988) and the dose of -0. 14 mg/kg used by Persson et al . (1989) . Figure 5 shows that the difference be tween the 2.5 and 0.25 mg/kg curves is significant in percentage principally after 40 min, but it can be difficult to see it using experimental data because of the experimental uncertainties. This explanation of the time-dependent results is probably incomplete since, for example, the time variation of the Kd value is not clear in Fig. 6C . Other phenomena, such as a low nonspecific binding, a small vascular fraction, or a potential uptake of labeled metabo lites into the brain, contribute to the errors in the estimated free ligand concentration.
The equilibrium approach in which the free ligand concentration is estimated from a receptor-poor re gion has not been studied because of the difficulty of obtaining in baboons a good quantification of the activity in pons or white matter regions. However, because of a possible small concentration of recep tor sites in these regions, the partial volume effect, and the different local blood flows, it is not surpris ing that this approach leads to similar difficulties.
DISCUSSION
Experimental protocol and fitting results
The aim of this multi-injection modeling approach is to estimate all of the model parameters from a single experiment. A complex protocol, including fo ur injections and requiring two syntheses due to the short half-life of IIC, has been chosen in order to obtain the two main parameters (B:nax and Kd V R) with the best possible accuracy. This approach was successful since the relative uncertainties on B:nax ranged from 4 to 10%, and those on Kd V R from 3 to 9%. However, the standard deviations obtained fr om the six experiments were larger since they were 22% for B:nax and 19% for Kd V R' This indi cates that the uncertainties resulting from the indi vidual variability, from the error on the specific activity measurement and from other various in strumental errors, cannot be reduced to <15%. Taking into account the number of parameters (only five since a nonspecific binding process does not need to be introduced), the proposed protocol can be considered too complex. A good estimation of all parameters could be obtained with a three-injection protocol including a tracer injection, only one dis placement, and a coil1iection. This protocol, com parable to the protocol used for example in Delforge et al. (1990b) , can be performed with only one syn thesis provided that the time between two injections is reduced to 30 min.
However, an experimental protocol too complex compared to the number of parameters to be iden tified has the advantage of giving redundant data, which are useless in routine examinations but are often interesting during preliminary studies. For ex ample, no systematic bias has been observed in comparing the experimental data and the model simulations, which gives arguments in favor of the structure of the mathematical model and in partic ular confirms that a nonspecific binding compart ment does not need to be introduced: either the nonspecific binding is negligible, as pointed out by Goeders and Kuhar (1985) , or a weak nonspecific binding exists, but with association-dissociation ki netic rate constants large enough that it can be in cluded in the free ligand compartment (Mintun et aI ., 1984 ; Perlmutter et aI ., 1986) . Moreover, the second displacement at 80 min clearly pointed out the phenomenom of rebinding: a ligand that disso ciates from a receptor site has a higher probability to rebind to the same or another free receptor site than to escape into capillary blood. The simulations show that the injection of 0.0 1 to 0.05 mg/kg of un labeled ligand led to a saturation of the receptor sites for only a short period of time (see Fig. 3B ). Thus, 20 min after the first displacement, a dissoci ated ligand has a probability of rebinding equal to 76%. This probability is calculated using the relation This percentage increases to 84% at 40 min after the displacement. This explains the small slopes 30 min after each injection of unlabeled ligand and why the second displacement at 80 min was again significant (�50%). It is likely that a third il1iection of unla beled ligand would lead to another significant de crease in the labeled ligand concentration.
Parameter values
The quantities of receptor sites available for in vivo binding B:nax estimated by this modeling ap proach were found to be similar in the occipital, temporal, and fr ontal cortices (from 75 to 64 pmoll ml), but one-half as large in the cerebellum (37 pmollml) . These values have the same order of mag nitude that the values obtained in baboons by Brouillet et al . (1990) using the equilibrium ap proach: 94-62 pmollml in the occipital cortex and 57-29 pmollml in the frontal cortex, decreasing with the time considered for the Scatchard analysis. In humans, B:nax values have been obtained using dif fe rent approaches (see Table 4 ): the kinetic method with an experimental protocol including two injec tions (the first one with low and the second one with The region of interest is the neocortex. Values deduced from Fig. 9 of Persson et aI., (1989) with the time varying from 20 to 55 min. e Neocortical region.
d Frontal region.
high specific activity) and in which the free ligand concentration is estimated by a receptor-poor re gion of reference (Blomqvist et aI ., 1990; Price et aI ., 1991) ; the equilibrium approach, where the fr ee ligand concentration is estimated from data ob tained by a fu ll-saturation experiment (Pappata et aI ., 1988; Iyo et aI ., 1991) ; and the equilibrium ap proach, with the free ligand concentration esti mated using a receptor-poor region of reference, usually the pons or the white matter (Persson et aI ., 1989; Blomqvist et aI ., 1990 ; Abadie et aI . , 1991; Price et aI ., 1991) . Table 4 shows that the order of magnitude of all B:nax estimates is similar. In four of the seven studies using an equilibrium approach, the authors found a dependency of the B:nax esti mates on the time used for the Scatchard analysis, and in all of these studies the result was decreasing with time . This modeling approach allows the estimation of the combined parameter Kd V R, where V R is the vol ume of reaction. This parameter is introduced in order to take into account the possibility that the volume of reaction between the free ligand and re ceptors does not correspond to the whole volume of tissue considered by PET. For example, in the case of a very hydrophilic molecule , VR is close to the fraction of extracellular fluid (see Delforge et aI ., 1990b) . Thus, for the local association and dissoci ation reactions, it is necessary to consider the con centration M(t)/VR in the volume of reaction VR rather than the quantities M(t) in 1 ml of tissue . The quantities per ml of tissue, which are the units of the equation system (3)-(6) , are obtained after multipli cation by V R' This approach does not modify the equation of the linear reactions (such as the disso ciation), but introduces a term lIVR in the specific binding since it is a bimolecular reaction.
J Cereb Blood Flow Metab, Vol, 13, No.3, 1993 The volume of reaction is not directly identifiable by PET. However, it can be estimated by assuming that the transfers between plasma and tissue are passive transfers . In such a case, the two parame ters p and k can be assumed to be equal, and thus V R can be estimated by comparing the two param eters p V R and k obtained by the PET modeling ap proach. From the values given in Table 3 , the vol ume of reaction is estimated to 0.50, 0.53, 0.52, and 0.51 mllml in occipital , temporal, fr ontal cortices, and cerebellum, respectively. It is interesting to note that the interregional variations of V R are very small compared to the interregional variations of p V R and k, which are related to local blood flow. The pVR values given in Table 3 are very close to the corresponding parameter (denoted by k l ) ob tained by Koeppe et aI . (1991) (0.313 min -I in oc cipital , 0.300 min -1 in fr ontal , and 0.263 min -1 in cerebellum) , by Gilman et aI . (1991) (from 0.28 to 0.32 min -I depending on the region) , and by Holthoff et aI . (1991) (from 0.29 to 0.37 min -1 ) .
The Kd V R values determined by the multi injection approach were found similar in the occip ital , temporal, and frontal cortices (from 8.4 to 8.1 nM) and slightly lower in the cerebellum (7 .3 nM). Taking into account the previous estimates of the volume of reaction VR (from 0.50 to 0.53 ml/ml) , the equilibrium dissociation constant Kd (which should correspond to the in vitro definition of this param eter) is estimated to be 16. 8, 15.8, 15.6, and 14 .3 nM in occipital , temporal and fr ontal cortices, and cer ebellum, respectively. However, other authors us ing PET did not include in their model the volume of reaction and therefore the Kd V R values obtained in this article have to be compared with the Kd values obtained by these authors (see Table 4 ) , who have implicitly set V R to 1. Like the results concerning the receptor concentrations, the estimates of K d have the same order of magnitude regardless of the authors and the approaches used.
Equilibrium condition and computer simulations
All authors indicate that the equilibrium relation ship, recalled by Eq. (I), is valid only if the model has reached an equilibrium state . However, the no tion of equilibrium is not always clearly defined in the literature . In in vitro studies, the system is closed and thus the definition is obvious: The equi librium is reached when both the fr ee and bound ligand concentrations become constant. However, in vivo studies, the exchanges with the blood circu lation make the concentration in all compartments always variable. In fact, since the equilibrium ap proach consists in using the equilibrium relation [Eq. (I)], the problem is to know the necessary con ditions that make this relationship valid .
Theoretically, the equilibrium relationship can be deduced from the evolution equations by imposing the criterion that the derivative of the bound ligand concentration equals zero. For example , with the notation used in this article, by imposing dMt, (t)ldt = 0 in Eq. (4) [and dMb(t)ldt = 0 in Eq. (6)] , the fo llowing equilibrium equation is obtained and is valid for both the labeled and unlabeled ligand con centrations:
This led some authors to use the Scatchard analysis only with the concentration estimated at the time corresponding to the maximum concentration of the bound ligand compartment (Farde et aI ., 1986 (Farde et aI ., , 1989 . However, as shown in Fig. 5 , the time of the maximum concentration depends on the injected dose, which is a difficulty for this Scatchard analy sis approach since the optimal time has to be cal culated for each curve. Some authors accept ap proximations and consider that the equilibrium state is achieved only when the radioactivity has reached a plateau . However, most of the authors consider that equi librium is reached when the ratio of Mt, (t)IMt (t) be comes a constant (the quasiequilibrium condition) , but no justification of the criterion is given (Pappata et aI., 1988; Persson et aI ., 1989; Brouillet et aI ., 1990) . In fact, this ratio is constant only after tracer injection but it is not valid after full or partial satu ration experiments, as shown in Fig. 4 , where the bound/free ratio appears to become rapidly con stant only after the first tracer injection. This result is not surprising since the simulation of the unla-beled bound concentration (shown in Fig. 3B ) indi cates that this concentration is significantly de creasing after each injection of unlabeled ligand. Therefore , the concentration of free receptor sites, given by B:nax -[Mt, (t) + Mb(t)] , is significantly variable ; this implies that the ratio given in relation ship (8) cannot be constant. Thus, this quasiequilib rium condition can be valid only when the number of free receptor sites is almost constant, and this is true only after a tracer injection, or after a period of time sufficient such that the percentage of occupied receptor sites become low (according to our simu lations , this period of time is at least 7-8 h) . Fortunately, our results show that, with the pa rameter values corresponding to the kinetics of FMZ, the validity of the equilibrium relationship (8) is broader than the validity of the quasi equilibrium condition (BIF constant) . Figure 4 shows the two calculations of the ratio of Mt,(t)IMt(t): the first one calculated directly by the ratio of concentrations using the simulated curves (shown in Fig. 3A) , and the second one deduced from the right side of rela tionship (8) using the known values of B:nax and K d V R' It appears that the two curves are similar, i.e., that relationship (8) is valid regardless of the time and the kind of the injection, except for a short period of time after each injection (less than 10 min) when the variation of the concentrations are too rapid . In fact, the equilibrium relationship is valid if the exchanges between the compartments are very rapid compared to the variation of the concentra tion in these compartments , i.e., if the derivative dMt, (t)ldt is low compared to the transfers between the two compartments. Indeed, relationship (4) can be written as dM�t)
and the equilibrium equation (8) can be rederived if one can assume that dMt, (t)ldt can be neglected compared to L ,Mt,(t).
Since the equilibrium relationship is valid with FMZ, provided that the time used for the Scatchard analysis is longer than 10 min after the injection, one could expect that the results obtained by the simulation of the equilibrium-Scatchard approach (shown in Fig. 6A ) are satisfactory . Indeed, the rel ative errors in B:nax and K d are 12 and 35%, respec tively. However, it is interesting to understand this bias, clearly visible in Fig. 6A . Our studies show that this bias is not a result of the approximation about the validity of the equilibrium relationship but is a consequence of the method used to estimate the free ligand concentration.
A new approach of the PET Scatchard analysis using two experiments In spite of the approximations and the bias that this study points out (see Fig. 6A ) , the Scatchard method has some advantages such as the ab sence of blood sampling. The most inconvenient aspect of the usual approach is the need to perform several experiments for each patient to obtain a large range of the bound ligand concentrations. The minimum number of experiments is three (see Abadie et aI ., 1991) but in such a case the B:nax and Kd are esti mated using a Scatchard plot including only two points.
However, the present simulation study shows that, with a good choice of doses, the percentage of receptors occupied varies significantly during the time of an experiment. For example, in Fig. 3B , this percentage varied spontaneously from 95% at 120 min to 53% at 200 min. The range could be amelio rated with well-adapted doses and a longer time in terval of measurement. Since the main problem of the Scatchard analysis is to obtain a large range of the bound ligand concentrations, the present results suggest that this range can be obtained fr om a single experiment, the Scatchard analysis being usable with all of the data corresponding to the period of time in which the equilibrium relationship is valid. Two experiments are necessary: first, a partial saturation experiment such that the percentage of occupied receptor ranges, e.g., from 70% at 20 min after the injection to 30% at the end of a I h exper iment; and , second, a full-saturation experiment al lowing the estimation of the corresponding free ligand concentration. The dose used for the partial saturation experiment has to be large enough so that the percentage of occupied receptors is significant but not too large; otherwise, this percentage will not decrease enough.
This method has been tested with data obtained by Brouillet et a1 . (1990) in baboons. Figure 8 shows the Scatchard plot obtained by this author (solid line) concerning the occipital cortex [cf. Figure 4 of Brouillet et a1 . (1990) ] and corresponding to eight experiments with various unlabeled doses, one of these experiments being a full-saturation experi ment used to estimate the free ligand concentration.
The proposed method has been tested using two of these eight experiments: the fu ll-saturation experi ment (2 mg/kg of FMZ) and a partial-saturation ex periment (0.01 mg/kg of FMZ). By using the esti mates of free and bound ligand concentrations at 10 times (every 10 min from 20 to 110 min) , we ob- Exa mple of comparison between the usual Scatchard analysis (solid circle) and the proposed method including only a partial-saturation experiment and a full-saturation ex periment (star). The data used were obtained by in the baboon occipital cortex. The seven solid circles correspond to eight experiments with various unla beled doses, one of these experiments being a full-saturation experiment used to estimate the free liga nd concentration. The stars correspond to the estimates of free and bound ligand concentrations at 10 ti mes (every 10 min fro m 20 to 110 min) of the partial-saturation experi ment . The two straight lines are the linear regression of the usual approach (solid li ne) and of the proposed method (dotted line).
tained 10 points in the Scatchard plot, represented in Fig. 8 with stars . The two straight lines in Fig. 8 correspond to the linear regression of the usual ap proach (solid line) and of the proposed method (dot ted line) . The two approaches led to very similar estimates of B:nax and Kd, but the obvious advan tage of the proposed method is to need only two experiments whereas the usual approach used by Brouillet needed eight experiments. However, one should keep in mind that this new method does not avoid the bias observed in Fig. 6A and results in underestimations of B:nax and Kd V R due to the ap proximation of free ligand concentration.
CONCLUSION
The multi-injection modeling approach allowed the in vivo quantification of benzodiazepine recep tors . The protocol used in this study was chosen in order to obtain a good estimate of the receptor con centration in spite of the experimental uncertain ties. However, it appears that future studies on an imals can be performed using a simplified protocol including only three injections and performed with only one synthesis of the radioligand . This protocol is usable for human studies. However, the complex ity of this experimental protocol is inconvenient, the main difficulty being the necessity of measuring the input fu nction using blood sampling.
The equilibrium approach is the most often used quantitation method in humans. Using the identified parameters , simulations showed that the hypothe ses of this approach are valid with FMZ, the equi librium relationship being validated due to rapid and continuous exchanges between the free and bound ligand compartments. However, this study pointed out the importance of a good estimation of the free ligand concentration, since most of the problems met with the equilibrium approach, such as the time-dependent results, are probably the conse quence of errors in the fr ee ligand concentration. We suggest a new approach to the PET Scatchard analysis using only two experiments: a partial saturation experiment and a fu ll-saturation one. This approach is more easily applicable for human studies than the usual Scatchard analysis, which re quires more experiments. These two experiments can be performed during a single 2 h examination using three injections: the first one corresponds to the partial-saturation experiment, the second one 50 min later is an injection of a large amount of unlabeled ligand, and the third one at time 70 min corresponds to the full-saturation experiment. The displacement experiment at 50 min provides a pre saturation of the receptor sites (to improve the fu ll-saturation experiment result) and a significant decrease in the labeled ligand concentration (which allows the elimination of a large part of the brain activity resulting fr om the first injection) .
Moreover, if the estimation of the fr ee ligand con centration using a receptor-poor region is validated in humans , the estimation of B:nax and Kd V R in hu mans will be possible fr om a single 1 h experiment, which is clearly acceptable for routine examination. These protocols, being entirely noninvasive , make it possible to investigate potential changes in ben zopiazepine receptor density and/or FMZ affinity in human patients.
